The maintenance of an Overweight rating by Morgan Stanley suggests a continued positive outlook on Docebo's stock. However, the reduction in the price target could reflect a cautious stance towards the company's valuation, potentially due to revised earnings expectations or market conditions. This adjustment is likely to have a neutral to slightly negative short-term impact on the stock price as it reflects optimism about the company's fundamentals but caution about its current valuation.